Axsome Therapeutics (NASDAQ:AXSM) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Axsome Therapeutics (AXSM) operate in?

Axsome Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Axsome Therapeutics Stock (NASDAQ: AXSM) stock price, news, charts, stock research, profile.

Open	$88.82
Close	$90.73
Volume / Avg.	956.38K / 481.47K
Day Range	$87.69 - $93.12
52 Wk Range	64.11 - 105.00
Market Cap	$4.41B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	17.49%
Days to Cover	14.19

Recent News

Axsome Therapeutics' AXS-12 Data For Sleeping Disorder Boosts Confidence In Approval And Market Potential, Analyst Says

Axsome's AXS-12 met Phase 3 trial goals, cutting cataplexy attacks by 77% over six months and improving cognition with a favorable safety profile.

Vandana Singh

FDA Accepts AXSM's NDA Resubmission for Migraine Drug, Stock Up

Axsome Therapeutics, Inc. (NASDAQ: AXSM) announced that the FDA has accepted its resubmitted new drug application (NDA) seeking approval for AXS-07 for the acute treatment of migraine.

Zacks

Axsome Banks on Auvelity & Sunosi to Fuel Growth

Axsome Therapeutics' (NASDAQ: AXSM) first marketed drug, Auvelity (AXS-05), was launched in the United States in 2022 for the treatment of major depressive disorder, making it the first approved drug in the company's portfolio.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$88.82
Close	$90.73
Volume / Avg.	956.38K / 481.47K
Day Range	$87.69 - $93.12
52 Wk Range	64.11 - 105.00
Market Cap	$4.41B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	17.49%
Days to Cover	14.19

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Axsome Therapeutics (AXSM) stock?

You can purchase shares of Axsome Therapeutics (NASDAQ:AXSM) through any online brokerage.

View our list of the best stock brokerages

Who are Axsome Therapeutics (AXSM) competitors?

Other companies in Axsome Therapeutics’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).

What is the forecast, or price target, for Axsome Therapeutics (AXSM) stock?

Axsome Therapeutics has a consensus price target of $118.39.

What is the current price for Axsome Therapeutics (AXSM)?

The stock price for Axsome Therapeutics (NASDAQ: AXSM) is $91 last updated December 20, 2024 at 4:52 PM EST.

Does Axsome Therapeutics (AXSM) pay a dividend?

There are no upcoming dividends for Axsome Therapeutics.

When is Axsome Therapeutics (NASDAQ:AXSM) reporting earnings?

Axsome Therapeutics’s Q4 earnings are confirmed for Tuesday, February 18, 2025.

Is Axsome Therapeutics (AXSM) going to split?

There is no upcoming split for Axsome Therapeutics.

What sector and industry does Axsome Therapeutics (AXSM) operate in?

Axsome Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Axsome Therapeutics

Axsome Therapeutics (AXSM) Forecast